CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ROIV — Roivant Sciences Ltd.
CIK 884546
SAN FRANCISCO, CA
Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$131,494,871
+$35,723,562 QoQ
Shares Held
3,715,594
+7.5% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#32
of 494 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. ROIV ranks #9 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in ROIV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,494,871 | 3,715,594 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $95,771,309 | 3,457,448 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $70,301,403 | 3,239,696 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $47,171,270 | 3,117,731 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $32,559,954 | 2,889,082 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $28,732,536 | 2,847,625 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $33,271,898 | 2,812,502 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $31,935,934 | 2,767,412 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $22,416,697 | 2,120,785 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $22,264,811 | 2,112,411 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $22,718,593 | 2,023,027 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $22,470,906 | 1,923,879 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,317,589 | 626,745 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,236,968 | 574,115 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,481,583 | 560,899 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,679,651 | 521,631 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,902,768 | 713,211 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,574,455 | 723,574 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,966,086 | 691,080 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||